PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 77 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,002,000 | +38.4% | 43,430 | -39.0% | 0.01% | -30.0% |
| Q3 2020 | $724,000 | -9.7% | 71,139 | +32.1% | 0.01% | -23.1% |
| Q2 2020 | $802,000 | +283.7% | 53,859 | +213.5% | 0.01% | +160.0% |
| Q1 2020 | $209,000 | -34.5% | 17,182 | -14.7% | 0.01% | +150.0% |
| Q4 2019 | $319,000 | – | 20,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,392,556 | $29,381,000 | 3.71% |
| Orbimed Advisors | 13,822,463 | $169,740,000 | 3.22% |
| Omega Fund Management, LLC | 668,908 | $8,214,000 | 2.54% |
| RA Capital Management | 3,363,605 | $41,305,000 | 2.46% |
| Boxer Capital, LLC | 1,123,105 | $13,792,000 | 1.00% |
| BVF INC/IL | 656,483 | $8,062,000 | 0.85% |
| DAFNA Capital Management LLC | 75,000 | $921,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 90,217 | $1,108,000 | 0.17% |
| Clal Insurance Enterprises Holdings Ltd | 292,000 | $3,586,000 | 0.09% |
| VHCP Management III, LLC | 4,408 | $54,000 | 0.03% |